TracXon joins the top 20 finalists in the Academic Startup Competition, gaining access to a six-month support program in 2024. The initiative targets startups driving impact across sectors like **lifesciences, biotech, digital health, and smart cities**. Selection emphasizes innovation in domains critical to healthcare, agriculture, and urban development.
Lucas Czentner, driven by personal experiences with cancer in his family, transitions from big pharma to academia to develop immunotherapies. As a PhD student at Utrecht University, he works on an innovative therapy alongside supervisor Gert Storm, aiming to commercialize the research. The project leverages both industry expertise and academic innovation to address unmet medical needs.
Lucas Czentner, a PhD candidate at Utrecht University, launches a company to advance clinical trials for a new immunotherapy cancer treatment he developed. The therapy showed strong effectiveness against aggressive cancers in mouse models during his research at the Department of Pharmaceutical Sciences. His initiative aims to translate preclinical findings into potential patient treatments.
